相似文献
1
[Progress on allogeneic hematopoietic stem cell transplantation in peripheral T cell lymphoma].
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):343-7. doi: 10.3760/cma.j.issn.0253-2727.2016.04.020.
2
Relapsed, refractory peripheral T-cell lymphoma not otherwise specified successfully treated with allogeneic haematopoietic stem cell transplantation.
Ceylon Med J. 2018 Jun 30;63(2):78-79. doi: 10.4038/cmj.v63i2.8672.
3
Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation.
Chin Med J (Engl). 2018 Sep 5;131(17):2105-2111. doi: 10.4103/0366-6999.239315.
4
Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis.
Ann Hematol. 2012 May;91(5):805-807. doi: 10.1007/s00277-011-1328-7. Epub 2011 Sep 6.
5
Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Best Pract Res Clin Haematol. 2013 Mar;26(1):89-99. doi: 10.1016/j.beha.2013.04.008. Epub 2013 May 25.
6
High-dose therapy and stem cell transplantation.
Semin Hematol. 2010 Apr;47 Suppl 1:S15-7. doi: 10.1053/j.seminhematol.2010.01.017.
7
Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.
Leuk Lymphoma. 2011 Jul;52(7):1382-6. doi: 10.3109/10428194.2011.569038. Epub 2011 May 23.
8
Successful allogeneic hematopoietic stem cell transplantation in a child with angioimmunoblastic T-cell lymphoma: A case report.
Pediatr Blood Cancer. 2023 Oct;70(10):e30497. doi: 10.1002/pbc.30497. Epub 2023 Jun 19.
9
Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.
Leuk Lymphoma. 2011 Aug;52(8):1415-7. doi: 10.3109/10428194.2011.573038.
10
Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
Ann Hematol. 2002 Nov;81(11):646-50. doi: 10.1007/s00277-002-0556-2. Epub 2002 Nov 9.
本文引用的文献
1
Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.
Future Oncol. 2015;11(11):1659-64. doi: 10.2217/fon.15.62.
2
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.
Clin Cancer Res. 2015 Jun 15;21(12):2666-70. doi: 10.1158/1078-0432.CCR-14-3119. Epub 2015 Mar 23.
3
Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Hematol Oncol. 2017 Mar;35(1):17-24. doi: 10.1002/hon.2201. Epub 2015 Mar 18.
4
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
Ann Oncol. 2015 Feb;26(2):386-92. doi: 10.1093/annonc/mdu515. Epub 2014 Nov 12.
5
Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis.
Acta Haematol. 2015;133(2):136-44. doi: 10.1159/000358579. Epub 2014 Sep 20.
6
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Ann Oncol. 2014 Nov;25(11):2211-2217. doi: 10.1093/annonc/mdu443. Epub 2014 Sep 5.
7
Romidepsin used as monotherapy in sequence with allogeneic stem cell transplant in a patient with peripheral T-cell lymphoma.
Case Rep Hematol. 2014;2014:404078. doi: 10.1155/2014/404078. Epub 2014 Jul 7.
8
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas.
Blood Cancer J. 2014 May 30;4(5):e214. doi: 10.1038/bcj.2014.34.
9
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma.
Leukemia. 2014 Sep;28(9):1885-91. doi: 10.1038/leu.2014.79. Epub 2014 Feb 20.
10
Peripheral T cell lymphoma in Asia.
Int J Hematol. 2014 Mar;99(3):227-39. doi: 10.1007/s12185-014-1520-3. Epub 2014 Jan 31.
Zotero 插件